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Abstract
Background: Bacterial populations communicate through the cell density-dependent mechanism of quorum
sensing (QS). Vibrio harveyi, one of the best studied model organisms for QS, was used to explore effects of the
synthetic cannabinoid HU-210 on QS and different QS-regulated physiological processes in bacteria.
Results: Analysis of QS-regulated bioluminescence in wild-type and mutant strains of V. harveyi revealed that HU-210
affects the autoinducer-2 (AI-2) pathway, one of three known QS cascades of V. harveyi. Furthermore, QS-mediated
biofilm formation and swimming motility in the mutant strain BB152 (AI-1−, AI-2+) were significantly reduced in the
presence of HU-210. HU-210 inhibited QS-mediated virulence factor production without any inhibitory effect on
bacterial growth. It also alters the expression of several genes, which are regulated by QS, specifically downregulating
the genes of the AI-2 QS cascade.
Conclusion: First evidence is being provided for interference of bacterial signal-transduction systems by a synthetic
cannabinoid. The effect of HU-210 was specific to the AI-2 cascade in V. harveyi. AI-2 is known as a "universal
autoinducer" and interference with its activity opens a broad spectrum of applications for synthetic cannabinoids
in future research as a potential anti-QS agent.
Background
Bacteria communicate and coordinate population behavior
through the mechanism of quorum sensing (QS), which
controls the expression of genes that affect a variety of
bacterial processes [1, 2]. QS is based on small signaling
molecules, termed autoinducers (AIs), which control
factors such as bioluminescence, pigment production, mo-
tility and biofilm formation, among many others [3–5].
The QS, free-living marine bacterium Vibrio harveyi
produces and responds to at least three distinct AIs [6]:
HAI-1, an acyl homoserine lactone [7]; AI-2, a furanosyl-
borate-diester [8]; and CAI-1, a long-chain amino ketone
(Z)-3-aminoundec-2-en-4-one (Ea-C8-CAI-1) [9]. AI-2 is
referred to "universal autoinducer" as it is found in numer-
ous Gram-positive and Gram-negative bacteria [10, 11]. A
better understanding of QS actions and novel ways to
affect them is providing an opportunity to manipulate bac-
terial properties that are of major importance in industry,
agriculture and medicine.
Plant and endogenous cannabinoids have been investi-
gated extensively, particularly as agonists of the endocan-
nabinoid signaling system and as therapeutically active
substances [12, 13]. Both delta-9-tetrahydrocannabinol
(THC), the major psychoactive constituent of cannabis
[14] and cannabidiol (CBD), a non-psychoactive constitu-
ent, alter immune functions, mostly via suppression. The
mechanism governing these activities has not been fully
elucidated (for a recent review see Cabral et al. [15]). In
most investigations, these phytocannabinoids have been
found to enhance the susceptibility of mice to microor-
ganisms (both bacteria and viruses). However, several
reports have indicated that administration of THC
leads to lower viral loads and moderation of disease
progression [15].
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The effect of cannabinoids on bacterial QS has never
been investigated. We chose to study the activity of the
synthetic cannabinoid HU-210 (Fig. 1), because its phys-
ical and chemical properties have been well defined.
HU-210 was first synthesized from (1R,5S)-myrtenol
[16]. It displays a multiplicity of biochemical, pharmaco-
logical, and behavioral effects, most of which depend on
its potent agonistic activity at the cannabinoid receptors
CB1 and CB2 [17].
Results
Effect of HU-210 on V. harveyi bioluminescence
To investigate the effect of HU-210 on the QS cascade
of V. harveyi wild-type strain BB120 and QS-mutant
strains (Table 1), bioluminescence was measured with
and without HU-210 in the growth media. First, we
determined whether addition of HU-210 to the growth
media alters the bioluminescence of the wild-type V.
harveyi strain. Results showed no significant difference
in bioluminescence between samples with and without
HU-210 (Fig. 2a). The experiments were repeated with
other V. harveyi strains mutated in the QS cascade.
Addition of HU-210 to the growth media resulted in an
up to 98 % decrease in the bioluminescence of V. harveyi
mutant BB152 (AI-1−, AI-2+), in a dose-dependent man-
ner, whereas bioluminescence of the mutant strain MM30
(AI-1+, AI-2−) was not significantly affected (Fig. 2a).
However growth of V. harveyi mutant BB152 (Fig. 2b)
and other mutant strains (data not shown) was not
affected by HU-210. Results indicated that a notable
effect of HU-210 was specific to AI-2 in the QS cascade
of V. harveyi, as this AI regulates QS of V. harveyi
mutant strain BB152.
To further analyze the mode of action of HU-210, an-
other mutant strain, BB170 (Sensor-1−, Sensor-2+) was
tested. Bioluminescence in V. harveyi BB170 is mainly
controlled by AI-2, as this strain is not responsive to
AI-1 stimulation due to the absence of sensor-1 [18]. In
the presence of HU-210, bioluminescence production
by mutant strain BB170 was decreased by up to 85 %,
further confirming the specific action of HU-210 on AI-2
(Fig. 2c). To validate the molecular QS target of HU-210,
another experiment was designed in which mutant strain
MM77 (AI-1−, AI-2−), in the absence or presence of differ-
ent doses of HU-210, was simultaneously incubated with
10 % (v/v) spent medium containing exogenous AI-1 and
AI-2 isolated from V. harveyi MM30 (AI-1+, AI-2−) and
BB152 (AI-1−,AI-2+) respectively. The inhibitory effect of
HU-210 on bioluminescence production was more pro-
nounced in samples to which exogenous AI-2 had been
added (~95 % decrease), suggesting that the effect of HU-
210 is not only on the production of AI-2 signal, but also
on the reception of those signal molecules by hybrid sen-
sor kinases present in mutant strain MM77 (Additional
file 1: Figure S1).
Interestingly when mutant strain BB152 (AI-1−, AI-2+)
was supplemented with exogenous AI-1 from MM30
(AI-1+, AI-2−) and simultaneously treated with different
concentrations of HU-210, the latter's dose-dependent
inhibitory effect could be reversed and bioluminescence
level of this mutant strain restored to the similar level
of the wild-type BB120, except in sample with highest
HU-210 concentration (200 μg/ml) (Fig. 2d).
Effect of HU-210 on V. harveyi biofilm biomass and DNA
quantity
The effect of HU-210 on other QS-controlled processes in
V. harveyi, such as biofilm formation, was also tested.
Biofilms were grown with and without different concen-
trations of HU-210 using different V. harveyi strains
(Table 1). The biofilm biomass formed by the different
strains was quantified using crystal violet (CV) staining.
The effect of HU-210 on biofilm biomass formed by
wild-type BB120 and mutant strain MM30 was min-
imal, as no significant decrease was observed with in-
creasing concentrations of HU-210 (Additional file 1:
Figure S2). Consistent with these results, an up to 80 %
decrease was observed in biofilm biomass of mutant
strain BB152 (AI-1−, AI-2+). Inhibition of biofilm bio-
mass formation by HU-210 in mutant BB152 was found
to be dose-dependent (Additional file 1: Figure S2).
Fig. 1 Chemical structure of the synthetic cannabinoid HU-210, used
in this study
Table 1 V. harveyi strains used in this study
V. harveyi strain Relative genotype Relative phenotype
BB120 Wild type AI-1+, AI-2+; sensor-1+,
sensor-2+
BB152 (BB7 or BB120) luxLM::Tn5 AI-1−, AI-2+; sensor-1+,
sensor-2+
MM30 (BB120) luxS::Tn5 AI-1+, AI-2−; sensor-1+,
sensor-2+
MM77 luxLM::Tn5, luxS::Tn5 AI-1−, AI-2−; sensor-1+,
sensor-2+
BB170 luxN::Tn5 AI-1+, AI-2+; sensor-1−,
sensor-2+
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This anti-biofilm effect was further confirmed using a
DNA-quantification method which specifically quanti-
fied the DNA present in different V. harveyi biofilms.
DNA quantification results showed the same trend of
inhibitory action for HU-210: biofilm in the mutant
strain BB152 was dose-dependently inhibited by up to
80 % (Fig. 3), whereas there was no significant decrease
in the amount of DNA present in wild-type BB120 and
mutant MM30 biofilms.
Biofilm depth, bacterial viability and presence of
extracellular polysaccharides (EPS)
To further evaluate the effect of HU-210 on biofilm for-
mation by V. harveyi, we analyzed the morphology of the
biofilms generated by the V. harveyi wild type BB120, and
mutants MM30 (AI-1+, AI-2−) and BB152 (AI-1−, AI-2+)
using confocal laser scanning microscopy (CLSM). The
depth of the biofilms formed by the wild type and mutant
strain MM30 was least affected by the addition of HU-
210. However biofilms formed by mutant BB152 in
control samples (without HU-210) were more confluent
(95 μm) than those formed in the presence of HU-210
(55 μm), and showed a gradual decrease in average depth
with increasing concentrations of HU-210 (Fig. 4a & b).
The amount of EPS was normalized to live cells in the
biofilm, and we observed less EPS in biofilms formed by
all tested V. harveyi strains in the presence of HU-210
vs. controls. However, the decrease was only significant
for mutant strain BB152, where up to 75 % less EPS was
measured in the presence of 200 μg/ml HU-210 vs. con-
trols. Bacterial cell viability in the biofilms was not signifi-
cantly affected by HU-210 in any of the tested V. harveyi
strains (Table 2).
Effect of HU-210 on swimming motility of V. harveyi
Swimming motility assays were performed with wild-
type strain BB120 and mutant strains MM30 and BB152.
A significant decrease (P < 0.05) in swimming motility
was observed in all three strains in the presence of the
highest tested concentration of HU-210 (200 μg/ml).
This effect of HU-210 was most evident in mutant strain



















































































































Fig. 2 Effect of HU-210 on growth and bioluminescence production of V. harveyi. (a) Comparison of relative bioluminescence production by V. harveyi
BB120 (wild type), MM30 (AI-1+, AI-2−) and BB152 (AI-1−, AI-2+) with different HU-210 concentrations, presented as area under the curve. (b) Growth
curve of V. harveyi BB152 with different HU-210 concentrations. (c) Relative bioluminescence production by V. harveyi BB170 (Sensor-1−, Sensor-2+) with
different HU-210 concentrations. (d) Relative bioluminescence production by V. harveyi BB152 with different HU-210 concentrations and simultaneous
supplementation with exogenous AI-1 isolated from V. harveyi MM30 (AI-1+, AI-2−), presented as area under the curve. Presented data are means and
SD of three independent experiments, each performed in triplicate.*P < 0.05 compared with control
Soni et al. BMC Microbiology  (2015) 15:159 Page 3 of 10
motility at lower concentrations as well (above 2 μg/ml)
(Fig. 5). In both the wild-type strain BB120 and the mu-
tant strain BB152, the observed reduction in swimming
motility was dose-dependent (up to 80 % and 85 %,
respectively), whereas in mutant strain MM30, up to
95 % inhibition was observed at the highest HU-210
concentration tested (200 μg/ml).
Effect of HU-210 on mRNA levels of different genes involved
in QS regulation
The molecular basis of the inhibitory action of HU-210
on QS and biofilm formation in V. harveyi mutant strain
BB152 was investigated. We quantified mRNA levels of
six genes which had been previously found to be regu-
lated by the AI-1- and AI-2-dependent QS in Vibrio.
Genes specific to the AI-2 QS cascade—luxS, luxP and
luxQ—were downregulated in the presence of 2 μg/ml
HU-210 in wild-type BB120 and mutant BB152, whereas
genes specific to the AI-1 cascade—luxM and luxN—were
upregulated in wild-type BB120 and mutant strain MM30.
Significant downregulation of AI-2 synthase luxS and
master regulator luxR was only observed in mutant strain
BB152 treated with HU-210 (Table 3). Results suggested
that HU-210 can inhibit QS through the AI-2 cascade by
inhibiting the production of AI-2 signal molecules
through luxS. Furthermore, decreased expression of luxP
and luxQ in mutant strain BB152 also suggested that the
mechanism of action proceeds through these hybrid sen-
sor kinases. As an outcome, there was less expression of
luxR—the master regulator of QS target genes—resulting
in suppressed activity of the AI-2-mediated QS cascade
present in mutant strain BB152. This could also explain
the specific inhibitory effect of HU-210 on biolumines-
cence, biofilm-forming ability and swimming motility of
mutant strain BB152 observed throughout the study.
Discussion
Bacteria communicate via QS using extracellular chemical
signaling molecules. AI-2 used for QS signaling is found
in both Gram-positive and Gram-negative bacteria. Recent
studies have focused on finding small molecules analogous
to AIs which can alter QS-regulated pathogenic behaviors
and biofilm formation in bacteria [19]. The action of can-
nabinoids on microbes and viruses has been documented
[15]. However their effect on bacterial QS pathways is
unknown.
V. harveyi is one of the best-characterized model or-
ganisms for the study of QS [20, 21]. Therefore, we inves-
tigated the effect of the potent synthetic cannabinoid HU-
210 on QS-regulated bioluminescence, biofilm formation
and swimming motility of V. harveyi strains. Further re-
search on cannabinoid–bacteria interactions will involve
exploring more derivatives and their effects on other types
of bacteria.
Our study focused mainly on the effect of HU-210 on
QS-mediated pathways at concentrations below the
minimum inhibitory concentration (MIC). Growth of
V. harveyi strains was unaffected at all tested concen-
trations (0.2–200 μg/ml) of HU-210. In experiments
with V. harveyi wild-type strain BB120 and mutant
strains BB152 and MM30, HU-210 only significantly
reduced bioluminescence of the mutant strain BB152.
Strain BB152 is a HAI-1 synthase mutant and inhibition
of its bioluminescence by HU-210 led us to postulate that
this synthetic cannabinoid acts on the AI-2 mediated QS
cascade. Using the bioluminescence reporter strain BB170
(Sensor-1−, Sensor-2+), we were able to address the spe-
cific inhibitory action of HU-210 on AI-2. The mutant
BB152 (AI-1−, AI-2+) was incubated simultaneously with
different doses of HU-210 and exogenous AI-1 and
assessed for further effects of HU-210. Interestingly, ex-





































Fig. 3 DNA quantification by qPCR. Comparison of quantified DNA of V. harveyi BB120 (wild type), MM30 (AI-1+, AI-2−) and BB152 (AI-1−, AI-2+) biofilm
formed with or without different concentrations of HU-210. Presented data are means and SD of three independent experiments, each performed in
triplicate.*P < 0.05 compared with control
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complementation by exogenous AI-1 for the dose-
dependent effect of HU-210, except in samples with the
highest tested HU-210 concentration (200 μg/ml). This
could be because at the highest concentration (200 μg/
ml), HU-210 strongly inhibited AI-2 activity (~95 %
decrease) in BB152 and the observed bioluminescence
production was due only to the excess exogenous AI-1
available at the time.
The plant kingdom is a well-known source of medi-
cines, including numerous antimicrobial agents. Several
other quorum-quenching molecules have been isolated
from plants [22]. For example, the plant constituent cur-
cumin was recently shown to interfere with QS-mediated
bioluminescence production in V. harveyi [23]. Similarly,
extracts of garlic have been shown to block QS of Pseudo-
monas aeruginosa [24], and vanilla extracts are capable of
interfering with QS in Chromobacterium violaceum [25].
Previous studies have confirmed that biofilm formation
is one of the primary attributes toward bacterial pathogen-

















































Fig. 4 Analysis of V. harveyi biofilms by CLSM. (a) Comparison of biofilm depth of V. harveyi BB120 (wild type), MM30 (AI-1+, AI-2−) and BB152 (AI-1−, AI-2+)
formed with or without different concentrations of HU-210. Presented data are means and SD of three independent experiments.*P < 0.05 compared
with control. (b) V. harveyi BB120 (wild type), MM30 (AI-1+, AI-2−) and BB152 (AI-1−, AI-2+) biofilms grown with or without HU-210 (200 μg/ml) and
stained with SYTO 9 dye (green), which stains live bacteria, and with concanavalin A–Alexa Fluor 647 conjugates (blue), which stain extracellular
polysaccharides. Biofilm depth of V. harveyi BB120 (wild type), MM30 (AI-1+, AI-2−) and BB152 (AI-1−, AI-2+) biofilms in control (without HU-210) is
85 μm, 80 μm ,95 μm and in samples with HU-210 (200 μg/ml) is 80 μm, 85 μm, 55 μm respectively
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of the present study suggest that HU-210 at the tested
concentrations significantly inhibited the biofilm-forming
capability of V. harveyi mutant strain BB152 (AI-1−, AI-2
+). The amount of total biomass in the biofilm, deter-
mined by CV staining and DNA quantification, decreased
with increasing concentration of HU-210. Since the in-
hibitory action of HU-210 was more prominent in the
mutant strain BB152 (AI-1−, AI-2+) than in the other
tested V. harveyi strains, HU-210 seems to interfere with
the AI-2-dependent QS pathway, resulting in less QS and
ultimately less biofilm formation. Results of the current
study are consistent with previous observations made in
Vibrio spp. wherein a pytochemical, resveratrol signifi-
cantly reduced total biofilm bimoass [27].
The anti-biofilm effect of HU-210 was further con-
firmed by CLSM observation of biofilm architecture,
showing a significant decrease in the depth of the biofilm
formed by mutant BB152; however, there was no such
effect on biofilm formed by wild-type strain BB120 or
mutant strain MM30. The average thickness of the biofilm
formed by these strains remained almost the same in HU-
210-treated and untreated samples. The substantial reduc-
tion in biofilm thickness for strain BB152 was comparable
to the result of a study in which S6-15, an extract from
the marine bacterium Bacillus pumilus, was shown to be
effective against biofilm formation in a wide range of
Gram-positive and Gram-negative bacteria [28].
Bacterial motility is an important virulence factor in
many pathogens. Some Vibrio spp. (including V. harveyi)
possess dual flagellar systems that are suited to move-
ment under different conditions [29]. A recent study
reported that QS enhances flagellar motility in patho-
genic V. harveyi [30]. To further investigate the effect
of HU-210 on QS, we checked its possible impact on
swimming motility of V. harveyi. The results indicated
an inhibitory effect of HU-210 on QS via its restrictive
effect on the motility of the wild type as well as mutant
strains BB152 and MM30. Observations from this study
fall in line with another study in which curcumin was
shown to affect swimming motility of V. harveyi [23].
Table 2 Analysis of biofilms formed by V. harveyi strains in the
presence/absence of HU-210
V. harveyi strains Flourescence Intensity
with/without HU-210 Live/Dead Relative EPS/Live Percentage
BB120 2.40 ± 1.23 100 ± 0
BB120 + 200 μg/ml HU-210 2.80 ± 1.13 45.98 ± 8.71
MM30 1.60 ± 0.99 100 ± 0
MM30 + 200 μg/ml HU-210 2.81 ± 1.15 88.75 ± 2.94
BB152 1.89 ± 0.69 100 ± 0
BB152 + 200 μg/ml HU-210 3.63 ± 0.03 25.50 ± 4.50*
Based on data obtained from CLSM. Fluorescence intensity was measured
using Image J software. Presented




































Fig. 5 Comparison of swimming motility of V. harveyi BB120 (wild type), MM30 (AI-1+, AI-2−) and BB152 (AI-1−, AI-2+) with different concentrations
of HU-210 quantified using Image J Software. Presented data are means and SD of two independent experiments (*P < 0.05)
Table 3 Relative mRNA expression of different genes in V. harveyi
Relative mRNA expression BB120 MM30 BB152
with HU-210 (2 μg/ml) RQ value
luxS 0.81 ± 0.03 - 0.42 ± 0.05*
luxP 0.98 ± 0.45 - 0.37 ± 0.25
luxQ 1.1 ± 0.65 - 0.36 ± 0.11
luxM 3.05 ± 0.46 4.04 ± 1.42 -
luxN 1.31 ± 0.31 2.34 ± 0.87 -
luxR 0.45 ± 0.12 1.34 ± 0.19 0.43 ± 0.11*
Relative expression of genes was measured using real-time RT-PCR as
described in Materials and Methods. Fold change of the transcriptional level
was calculated using ABI-Prism 7300 software v1.1 with RQ study 1.0, Applied
Biosystems. The expression results represent mean ± SD of two independent
experiments. *P < 0.05
Soni et al. BMC Microbiology  (2015) 15:159 Page 6 of 10
Biofilm formation is a developmental process due to
changes in the structural and regulatory genes required
at various steps of its formation [31–33]. To unveil the
molecular basis of V. harveyi BB152 bioluminescence
and biofilm inhibition by HU-210, we measured differ-
ential expression of genes regulating QS-phenotypes in
the presence and absence of HU-210. In V. harveyi, the
AI-2-mediated QS system is composed of LuxS, LuxP
and LuxQ. LuxS is responsible for the synthesis of AI-2
[8]. LuxP is a periplasmic protein that binds AI-2, and
LuxQ is a hybrid sensor kinase. Lux R is the master
regulator of all three parallel QS systems in V. harveyi
[34]. We observed less expression of luxS, luxP, luxQ
and luxR in mutant strain BB152 treated with HU-210,
suggesting that this cannabinoid interferes with AI-2
production, as well as with reception of these QS signals
by sensor kinases, resulting in lower activity of LuxR
and less activation of QS target genes. This notion is in
agreement with several other reports showing disruption
of QS-regulated gene expression in V. harveyi by haloge-
nated furanone [35, 36].
It has been reported that three QS systems work in
parallel, based on a coincidence detection scheme, to
regulate different genes' expression in V. harveyi [4]. We
noticed that luxM (AI-1 producer) and luxN (hybrid
sensor kinase which perceives AI-1) in wild-type BB120
as well as in mutant strain MM30 were upregulated in
the presence of 2 μg/ml HU-210. It has been recently
shown that in a growing wild-type V. harveyi culture,
AI-2 synthesis is quickly followed by that of HAI-1 [21].
Based on this knowledge, it becomes evident that the
observed limited effect of HU-210 on wild-type BB120
bioluminescence and biofilm formation is a result of the
coincidence detection scheme in which AI-1 of BB120
(AI-1+, AI-2+) complements the QS system when AI-2
activity is interfered with by HU-210.
The present study is the first report on the effect of a
cannabinoid on QS-mediated processes, namely bio-
luminescence, biofilm formation and swimming motility
of a bacterial species. The inhibitory action of HU-210
was found to proceed through AI-2 and it was the result
of altered expression of genes involved in the AI-2 QS
cascade. AI-2 is known as the "universal autoinducer"
and interference in its activity opens a broad spectrum
of applications for synthetic cannabinoids in future re-
search with prokaryotes. Further investigations need to
be carried out to establish the molecular aspects and
mode of action of cannabinoids' effects on QS.
Conclusions
The synthetic cannabinoid HU-210 has an inhibitory ef-
fect on QS and QS-dependent properties, such as bio-
luminescence, biofilm formation and swimming motility
of V. harveyi, without affecting its growth. Furthermore,
HU-210's effect was found to proceed through the AI-2-
mediated QS cascade. Results of the present study sug-
gest a novel mode of action for synthetic cannabinoids
on bacteria via the bacterial communication system, and
potential use of cannabinoids as anti-QS agents.
Methods
Bacterial strains and growth
V. harveyi wild-type and mutant strains (Table 1) were
grown aerobically overnight at 30 °C in AB-medium. Bac-
terial strains were kindly provided by B. Bassler (Princeton
University).
HU-210 preparation
HU-210 was synthesized as described previously [37]: m.p.
140–1 °C (from pentane), [α]D -227 (CHCl3), δ (CDCl3)
6.40, 6.25 (2 arom H's), 5.6 (C = CH), 4.09 (CH2–O). Stock
solutions were prepared by dissolving 5 mg HU-210 in
250 μl of 100 % ethanol and stored at 4 °C until use.
Working concentrations were prepared from the stock
solutions by diluting with sterile AB-medium to final
concentrations of 0.2–200 μg/ml.
MIC determination
V. harveyi wild-type strain BB120 was grown at 30 °C in
the presence of HU-210 at concentrations ranging from
2–4 mg/ml in 96-well transparent plates (Nunc, Roskilde,
Denmark). After 24 h of incubation, bacterial growth was
determined by absorbance at 595 nm (OD595) (TECAN
GENios reader, Schweiz, Austria). The MIC was recorded
as the minimum concentration that exhibited visible
growth inhibition and all further experiments were per-
formed at sub-MIC [38].
Bioluminescence assay
QS regulates bioluminescence in V. harveyi [39]. For
the bioluminescence assay, V. harveyi overnight culture
(O.D595 ~ 0.7) was diluted 1:200 in fresh AB-medium
along with different concentrations of HU-210. After
dilution, 180 μl bacterial culture was transferred to 96-
well white plates with an optic bottom (Nunc) and the
readings were taken using the GENios reader at 30 °C.
Luminescence was measured every 30 min in parallel
with absorbance measurement (OD595) for 18 h. Rela-
tive luminescence unit (the amount of luminescence
per unit of growth) was calculated as the quotient of
luminescence value and growth for each well. The area
under the curve was calculated for each sample, compared
with a control sample (without HU-210) and reported as a
percentage [38, 40].
Biofilm biomass quantification using the CV method
Biofilm biomass was quantified by CV staining as de-
scribed previously [41] with slight modifications. Briefly,
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a 96-well polystyrene plate (Nunc) was seeded with 20 μl
of V. harveyi overnight culture (O.D595 ~ 0.7) followed
by addition of 160 μl AB-medium and 20 μl of HU-210
at different concentrations for biofilm growth. The plate
was incubated for 24 h at 30 °C. Generated biofilms were
washed carefully twice using 200 μl saline solution. The
biofilms were stained with 200 μl of 0.1 % (w/v) CV
(Merck, Darmstadt, Germany) solution for 20 min, then
washed twice with saline and the stained biofilms were
dried overnight at room temperature. Next, 33 % acetic
acid was added to elute the CV for 60 min along with
shaking at room temperature. The extract was trans-
ferred to a new 96-well plate and OD595 was measured
using the GENios reader.
DNA quantification by quantitative (q) PCR
For biofilm growth, a polystyrene 48-well plate (Nunc)
was seeded with 50 μl of V. harveyi overnight culture
(O.D595 ~ 0.7) followed by addition of 400 μl AB-medium
and 50 μl HU-210 at different concentrations. The plate
was incubated for 24 h at 30 °C. Generated biofilms were
washed carefully twice using 500 μl of saline solution.
DNA extraction and quantification were performed
as described previously [42, 43]. Briefly, 160 μl NaOH
(0.05 M) (Bio Lab Ltd., Jerusalem, Israel) and 40 μl
DEPC-treated water (Bio Basic Canada Inc., Markham,
Ontario, Canada) were added to each well. The plate was
then immersed in a hot water bath for 1 h at 60 °C. Then,
18.5 μl Tris buffer (pH 7) (Eastman Kodak Company,
Rochester, NY, USA) was added to each well and extracted
DNA samples were stored at −20 °C until further use.
DNA samples from different V. harveyi biofilms were
quantified by qPCR with specific primers for 16S rRNA
using an ABI prism instrument (Applied Biosystems Prism
7300, Foster City, CA, USA). The amount of DNA was
quantified according to the specific standard curve. Total
genomic DNA was extracted from an overnight culture of
V. harveyi BB120 using GenElute Bacterial Genomic
DNA kit (Sigma Aldrich, St. Louis, MO, USA) as per the
manufacturer’s instructions. Extracted genomic DNA for
the standard curve analysis was stored at −20 °C.
Biofilm depth, cell viability and presence of EPS
Bacterial cell viability, presence of EPS and depth of the
biofilms grown as described above were examined by
CLSM (Olympus Fluoview 300, Tokyo, Japan) with a
UPLSA 10X/0.4 lens. The biofilm was formed by seeding
20 μlV. harveyi overnight culture (O.D595 ~ 0.7), 160 μl
AB- medium and 20 μl of HU-210 at different concentra-
tions in a 96-well plate (Nunc). The plate was incubated
for 24 h at 30 °C under aerobic conditions. Biofilms
were then washed carefully with saline solution and
stained for 20 min at room temperature with different
stains. Biofilms were washed again with saline solution
before visualization under the microscope.
To examine cell viability, biofilms were stained with
LIVE/DEAD BacLight fluorescent dye (Life Technologies,
Carlsbad, CA, USA). SYTO9 fluorescence was measured
using 488 nm excitation and 515 nm emission filters, and
propidium iodide (PI) fluorescence was measured using
543 nm excitation and 570 nm emission filters (Olympus).
EPS were stained with concanavalin A–Alexa Fluor 647
conjugates (Invitrogen Molecular Probes, Carlsbad, CA,
USA). The biofilm depth was determined by acquiring
optical sections at 5-μm spacing using a previously de-
scribed method [31]. Biofilm depth was examined at the
center of each well and quantified as the distance between
the highest and lowest section. Fluorescence intensity per
unit area was calculated using Image J software (National
Institutes of Health) for each color separately.
Swimming motility assay
The swimming motility assay was performed on soft
agar plates using a previously described method [30]
with some modifications. Briefly, AB-medium with 0.2 %
(w/v) agar was prepared and autoclaved. After cooling to
60 °C, different concentrations of HU-210 were added
and the medium was poured into small petri dishes.
After solidification, 3 μlV. harveyi overnight culture
(O.D595 ~ 0.5) was inoculated at the center of the agar.
Agar plates without HU-210 served as controls. The
plates were incubated at 30 °C for 15 h, then the area of
the motility halo was measured using Image J software
and compared with controls.
RNA extraction
V. harveyi wild-type BB120 and mutant strains MM30
and BB152 were grown overnight planktonically with and
without (control) 2 μg/ml HU-210. V. harveyi overnight
culture (200 μl; O.D595 ~ 0.7) was added in triplicate to a
12-well polystyrene plate (Nunc) along with 1.6 ml AB-
medium and 200 μl HU-210 (2 μg/ml). The plate was
incubated for 24 h at 30 °C under aerobic conditions.
Following incubation, the bacterial culture in each well
was mixed vigorously and transferred to 10-ml tubes.
Further RNA extraction was performed using a previously
described method [32]. Briefly, 2 ml of RNA Protect
(Qiagen, Hilden, Germany) was added to each tube, mixed
well and incubated at room temperature for 5 min. Cells
were harvested and DNA-free RNA was isolated using the
RNeasy MINI kit (Qiagen) according to the manufac-
turer’s instructions. RNA purity and quantity were de-
termined using Nanodrop (Nanovue, GE Healthcare Life
Sciences, Buckinghamshire, UK). RNA integrity was deter-
mined using a bioanalyzer (Agilent, Santa Clara, CA,
USA) and the samples were stored at −80 °C for later use.
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Reverse transcription (RT) and real-time PCR
Reverse transcription was performed with the SuperScript™
First-Strand Synthesis Kit (Invitrogen, Life Technologies)
in accordance with the manufacturer’s instructions.
The synthesized cDNA was used for real-time PCR
analysis with specific primers for the genes examined in
this study. The RT-PCR was performed as described pre-
viously [44]. The PCR thermal profile included an initial
denaturation at 95 °C for 10 min, followed by a 40-cycle
amplification consisting of denaturation at 95 °C for 15 s
and annealing and extension at 60 °C for 1 min.
As an additional control for each primer pair and each
RNA sample, the cDNA synthesis reaction was performed
in the absence of reverse transcriptase in order to check
for contamination with residual genomic DNA. The ex-
pression levels of all genes tested by real-time PCR were
normalized to the 16S rRNA gene of V. harveyi as an
internal standard. There was no significant difference in
the expression of the 16S rRNA gene for the two condi-
tions and samples. Fold change of transcription level was
calculated using ABI Prism 7300 SDS Software v1.1 with
RQ Study 1.0 (Applied Biosystems) [43, 45].
Statistical analysis
Experiments were performed independently three times
in triplicate and the data were analyzed statistically using
Student's t test, with a P value of less than 0.05 consid-
ered significant.
Additional file
Additional file 1: Figure S1. Comparison of relative bioluminescence
production by V. harveyi MM77 (AI-1-, AI-2-, sensor-1+, sensor-2+) with
different HU-210 concentrations when simultaneously supplemented with
exogenous AI-1 and AI-2 from V. harveyi mutant strains MM30 (AI-1+, AI-2-)
and BB152 (AI-1-, AI-2+) respectively, presented as area under the curve.
Presented data are means and SD of three independent experiments, each
performed in triplicate. *P < 0.05. Figure S2. Biofilm biomass quantification
of V. harveyi wild type BB120, mutant strain MM30 and BB152 biofilms using
CV staining. The staining strength is an indication of the amount of
biofilm mass formed in AB –media with/without different concentrations of
HU-210. Graph represents calculation of biofilm biomass relatively with
control. Presented data are means and SD of three independent experiments,
each performed in triplicate. *P < 0.05 (DOC 827 kb)
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